4//SEC Filing
Geffken Daniel E. 4
Accession 0001209191-23-027199
CIK 0001534133other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:59 PM ET
Size
9.3 KB
Accession
0001209191-23-027199
Insider Transaction Report
Form 4
Geffken Daniel E.
Interim CFO
Transactions
- Award
Warrant
2023-03-20+11,520→ 11,520 total(indirect: By LLC)Exercise: $6.60Exp: 2030-11-09→ Common Stock (11,520 underlying) - Award
Warrant
2023-03-20+5,760→ 5,760 total(indirect: By LLC)Exercise: $10.42Exp: 2030-10-30→ Common Stock (5,760 underlying)
Footnotes (3)
- [F1]Immediately exercisable.
- [F2]Received in exchange for a warrant to acquire 400,000 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding warrant to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into a warrant to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
- [F3]Received in exchange for a warrant to purchase 200,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. Upon the closing of the Merger, each outstanding warrant to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into a warrant to purchase the Issuer's common stock
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
Related Parties
1- filerCIK 0001314756
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 8:59 PM ET
- Size
- 9.3 KB